Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study

被引:2
|
作者
Fayed, Amel [1 ,6 ]
Alzeidan, Rasmieh [2 ]
Elkouny, Roaa [3 ]
Tawfik, Marwa [4 ]
Naguib, Rania [5 ]
机构
[1] Princess Nourah bint Abdulrahman Univ, Coll Med, Clin Sci Dept, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia
[3] AlFaisal Univ, Coll Med, Riyadh, Saudi Arabia
[4] Alexandria Univ, Alexandria Fac Med, Internal Med Dept, Hepatobiliary Unit, Alexandria, Egypt
[5] Alexandria Univ, Fac Med, Internal Med Dept, Endocrinol Unit, Alexandria, Egypt
[6] Princess Nourah bint Abdulrahman Univ, Coll Med, Clin Sci Dept, POB 84428, Riyadh 11671, Saudi Arabia
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2023年 / 16卷
关键词
cardiovascular risk; diabetes; uncontrolled diabetes; Framingham risk score; Saudi Arabia; SCIENTIFIC STATEMENT; PHYSICAL-ACTIVITY; SAUDI-ARABIA; DISEASE; ADULTS; PREVENTION; PREVALENCE; OBESITY;
D O I
10.2147/IJGM.S404054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to estimate the risk of cardiovascular disease (CVD) among patients with and without diabetes mellitus (DM) using the Framingham risk score (FRS) and to investigate the effect of DM control on CVD risk.Methodology: A total of 2432 participants who had their glycosylated hemoglobin (HbA1c) measured within the last three months were included in this study. The study cohort was divided into three categories: non-diabetic, participants with controlled DM (HbA1c<7%), and uncontrolled DM (HbA1c >= 7%). The World Health Organization's stepwise approach to chronic disease risk factor Surveillance-Instrument v2.1 was used in this study to collect the anthropometric and biochemical measurements. The Framingham Coronary Heart Risk Score (FRS) was used to calculate the 10-year cardiovascular risk (CVR). The groups were compared concerning the prevalence of metabolic, socioeconomic, and cardiac risks. Results: Out of 2432 participants, 149 had controlled DM (6.1%), 286 had uncontrolled DM (11.8%), and 1997 participants were normoglycemic (82.1%). Compared to healthy participants, diabetic participants showed more high-risk characteristics across all CVR parameters. Uncontrolled diabetic patients had a graver laboratory and clinical profiles compared to the controlled DM group. As measured by FRS, nearly half of patients with controlled DM (49.9%) and two-thirds of patients with uncontrolled DM (63.3%) were classified as intermediate and high-risk compared to 4.6% of the healthy participants. Compared to healthy participants, patients with controlled DM showed a threefold increased CVR (OR = 3.02, 95% C.I. = 1.41-7.24) while this risk catapulted to 13 times among those with uncontrolled DM (OR = 13.57, 95% C.I. = 6.99-26.36). Conclusion: Participants with DM are at moderate to high CVR. Individuals with uncontrolled DM showed higher CVR profiles as measured by FRS and have a higher prevalence of obesity, unhealthy diet, and physical inactivity.
引用
收藏
页码:1171 / 1180
页数:10
相关论文
共 50 条
  • [31] Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes
    De Cosmo, Salvatore
    Rossi, Maria Chiara
    Pellegrini, Fabio
    Lucisano, Giuseppe
    Bacci, Simonetta
    Gentile, Sandro
    Ceriello, Antonio
    Russo, Giuseppina
    Nicolucci, Antonio
    Giorda, Carlo
    Viazzi, Francesca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (03) : 657 - 662
  • [32] Smoking Behavior Change and the Risk of Heart Failure in Patients With Type 2 Diabetes: Nationwide Retrospective Cohort Study
    Yoo, Jung Eun
    Jeong, Su-Min
    Lee, Kyu Na
    Lee, Heesun
    Yoon, Ji Won
    Han, Kyungdo
    Shin, Dong Wook
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10
  • [33] The risk of type 2-diabetes among persons with intellectual disability: a Danish population-based matched cohort study
    Thorsted, A.
    Lehn, S. F.
    Kofoed-Enevoldsen, A.
    Andersen, A.
    Heltberg, A.
    Michelsen, S. I.
    Thygesen, L. C.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2025, 69 (01) : 90 - 102
  • [34] Study of cardiovascular risk factors in Tunisian patients with recent type 2 diabetes
    Bouzid, K.
    Ben Miled, F. Ben Mami
    Hassine, M.
    Kalai, E.
    Ben Ahmed, H.
    Boujnah, R.
    Achour, A.
    Bahlous, A.
    Abdelmoula, J.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (02): : 81 - 87
  • [35] Impact of vision and hearing impairments on risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: A nationwide cohort study
    Jung, Younhea
    Han, Kyungdo
    Lee, Ji Min
    Park, Hye Yeon
    Moon, Jung Il
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) : 515 - 524
  • [36] Impact of mental disorders on the risk of heart failure among Korean patients with diabetes: a cohort study
    Yoo, Tae Kyung
    Han, Kyung-Do
    Rhee, Eun-Jung
    Lee, Won-Young
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [37] Incidence of depression in patients with cardiovascular disease and type 2 diabetes: a nationwide cohort study
    Zareini, Bochra
    Sorensen, Katrine Kold
    Blanche, Paul
    Falkentoft, Alexander C.
    Fosbol, Emil
    Kober, Lars
    Torp-Pedersen, Christian
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (11) : 1523 - 1533
  • [38] Perception of diabetes management and cardiovascular disease risk among men with type 2 diabetes: A qualitative study
    Nabolsi, Manar M.
    NURSING OPEN, 2020, 7 (03): : 832 - 840
  • [39] The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study
    de Haan-Du, Jing
    Landman, Gijs W. D.
    Groenier, Klaas H.
    Vissers, Pauline A. J.
    Louwman, Marieke W. J.
    Kleefstra, Nanne
    de Bock, Geertruida H.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2114 - 2121
  • [40] Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study
    Calvo-Hueros, Juan Ignacio
    Martin-Hidalgo-Barquero, Maria Victoria
    Morales-Gabardino, Jose Antonio
    Buitrago, Francisco
    PRIMARY CARE DIABETES, 2021, 15 (02) : 391 - 396